Both in Pharmaceuticals
Cingulate vs MAIA Biotechnology
Over the past year CING returned +26.1% and MAIA returned −28.1%; their daily moves had a correlation of 0.15.
CING +26.1% MAIA −28.1%Growth of $1, one year, split-adjusted
| Metric | CING | MAIA |
|---|---|---|
| Price | $4.91 | $1.15 |
| Market cap | $71.3M | $71.0M |
| Today | +1.76% | −2.54% |
| 1 month | −7.9% | −13.5% |
| 6 months | −16.0% | −12.2% |
| Year to date | +13.0% | −24.8% |
| 1 year | +28.7% | −29.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $23.3M | $27.6M |
| Dividend yield | — | — |
| Volatility (60d) | 42.8% | 48.9% |
| Short % of float | 13.2% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).